Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey-Reference-Cited by-同舟云学术

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey

Published:2024 Issue:3 Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Palaia Innocenza¹^ORCID,Caruso Giuseppe¹^ORCID,Di Donato Violante¹^ORCID,Turetta Camilla¹^ORCID,Savarese Antonella²^ORCID,Perniola Giorgia¹^ORCID,Gallo Roberta¹^ORCID,Giannini Andrea¹^ORCID,Salutari Vanda³^ORCID,Bogani Giorgio¹^ORCID,Tomao Federica¹^ORCID,Giannarelli Diana⁴^ORCID,Gentile Gabriella¹^ORCID,Musella Angela¹^ORCID,Muzii Ludovico¹^ORCID,Pignata Sandro⁵^ORCID,

Affiliation:

1. Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.

2. Department of Oncology, Regina Elena National Cancer Institute, Rome, Italy.

3. Division of Gynecologic Oncology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, Rome, Italy.

4. Biostatistic Unit, Regina Elena National Cancer Institute, Rome, Italy.

5. Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e70

Reference37 articles.

1. A metabolic view on menopause and ageing

2. Revised global consensus statement on menopausal hormone therapy

3. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis

4. Hormone therapy (HT) in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer: A Society of Gynecologic Oncology (SGO) clinical practice statement

5. Management of menopausal symptoms and ovarian function preservation in women with gynecological cancer